Clinical trial for RSV vaccine is recruiting adults to participate

Simple Health

AUSTIN (KXAN) — Researchers are ready to test possible vaccine candidates for the respiratory syncytial virus, or RSV, in a clinical trial.

Benchmark Research is recruiting adults over 18 for RSV vaccine clinical trials. The research institute previously conducted clinical trials of several coronavirus vaccines.

Dr. Laurence Chu, principal investigator at Benchmark Research, said it is a traditional vaccine similar in type to the flu vaccine. Unlike the flu vaccine, the test RSV vaccine will be isolating a specific protein for the body to create antibodies from and form memory cells, Dr. Chu said.

In June, the Texas Department of State Health Services (DSHS) issued a health advisory about the spike in RSV cases. RSV is spread through respiratory droplets and can cause long-term lung damage.

RSV is the most common cause of pneumonia in children under one year old. Older adults are also at risk of severe disease from RSV, according to DSHS.

To learn more information on the clinical trial and how to join, contact Benchmark Research.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Austin-Travis County

Top Stories

More Top Stories

Tracking the Coronavirus

Coronavirus Cases Tracker

Latest Central Texas COVID-19 Cases

Trending Stories

Don't Miss